According to a new report, published by KBV research, The Global Rhytidectomy Market size is expected to reach $4.3 billion by 2028, rising at a market growth of 8.4% CAGR during the forecast period.
The 40-54 Years segment is showcasing a CAGR of 8.8% during (2022 - 2028). The facelift procedure's widespread use in facial aging, facial contouring, and volume loss is credited with segment growth. Forty-nine thousand two hundred forty-six treatments were carried out on patients between 40 and 54, as stated by the Plastic Surgery Statistical Report 2020. Those showing signs of facial aging but still possessing some skin elasticity make them the greatest candidates for facelift surgery. Therefore, patients in their 40s to 50s are typically included and can be candidates for surgery.
The Full Facelift segment is leading the Global Rhytidectomy Market by Type in 2021 thereby, achieving a market value of $3.2 billion by 2028. The segment's expansion is attributable to the aging population's growing use of it. The older population is choosing facelift surgeries like secondary or tertiary rhytidectomy to alleviate issues from prior procedures and natural aging, according to a report published by National Center for Biotechnology Information (NCBI). As the proportion of aging people increases globally, the demand for a facelift would increase further.
The Male segment has shown the growth rate of 10.7% during (2022 - 2028). According to the Plastic Surgery Statistics Report, 8% of all cosmetic surgeries that year were performed on males. This value includes approximately 289,000 surgeries and 820,000 minimally invasive surgeries. Recent years have seen a rise in the number of males undergoing surgeries to improve their appearance and aesthetics. In addition, the greater influence of social media further boosts the number of males opting for cosmetic surgeries, thereby propelling the segment's growth.
The Hospitals segment acquired maximum revenue share in the Global Rhytidectomy Market by End-use in 2021 thereby, achieving a market value of $1.8 billion by 2028. The convenience provided by hospitals, along with the availability of highly qualified medical personnel, are credited with the increase. Moreover, the accessibility of state-of-the-art medical technology in healthcare facilities like hospitals is anticipated to propel market expansion throughout the forecast period. For example, the Plastic Surgery Statistics Report states that 43.8% of hospitals worldwide performed rhytidectomy procedures.
The North America market dominated the Global Rhytidectomy Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.5 billion by 2028. The Europe market is exhibiting a CAGR of 8% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 8.9% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/rhytidectomy-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of London Bridge Plastic Surgery, Piedmont Plastic Surgery & Dermatology, The Plastic Surgery Center, USA Health, ASET Hospital, Enhance Medical Group and BSR ENT Hospital.
By Age Group
By Type
By Gender
By End-use
By Geography
Companies Profiled
Unique Offerings 
